High Proportions of Multidrug-Resistant Acinetobacter spp. Isolates in a District in Western India: A Four-Year Antibiotic Susceptibility Study of Clinical Isolates

Ingvild Odsbu, Smita Khedkar, Uday Khedkar, Sandeep S. Nerkar, Ashok J. Tamhankar and Cecilia Stålsby Lundborg
Additional contact information
Ingvild Odsbu: Department of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden
Smita Khedkar: Bac-Test Laboratory, College Road, Nashik 422005, Maharashtra, India
Uday Khedkar: Bac-Test Laboratory, College Road, Nashik 422005, Maharashtra, India
Sandeep S. Nerkar: Department of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden
Ashok J. Tamhankar: Department of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden
Cecilia Stålsby Lundborg: Department of Public Health Sciences, Karolinska Institutet, 17177 Stockholm, Sweden

IJERPH, 2018, vol. 15, issue 1, 1-13

Abstract: The purpose of the study was to determine the proportions of multidrug-resistant (MDR) Acinetobacter spp. isolates from the district of Nashik in Western India during the period from 2011–2014. Antibacterial susceptibility testing of isolates from inpatients and outpatients was performed using Kirby–Bauer disc diffusion method to determine inhibitory zone diameters. Proportions of non-susceptible isolates were calculated from the antibacterial susceptibility data. MDR was defined as an isolate being non-susceptible to at least one antibacterial agent in at least three antibacterial categories. The change in proportions of MDR isolates; extended-spectrum β-lactamase (ESBL)-producing isolates; and non-susceptible isolates to specific antibacterial categories over calendar time was investigated by logistic regression. The proportions of MDR and ESBL-producing isolates ranged from 89.4% to 95.9% and from 87.9% to 94.0%; respectively. The proportions of non-susceptible isolates to aminoglycosides; carbapenems; antipseudomonal penicillins/β-lactamase inhibitors; cephalosporins; folate pathway inhibitors; or penicillins/β-lactamase inhibitors exceeded 77.5%. Proportions of fluoroquinolone and tetracycline non-susceptible isolates ranged from 65.3% to 83.3% and from 71.3% to 75.9%; respectively. No changes in trends were observed over time; except for a decreasing trend in fluoroquinolone non-susceptible isolates (OR = 0.75 (95% CI, 0.62–0.91)). Significantly higher proportions of non-susceptible; MDR and ESBL-producing isolates were found among isolates from the respiratory system compared to isolates from all other specimen types ( p < 0.05). High proportions of MDR Acinetobacter spp. isolates were observed in the period from 2011–2014. Antimicrobial stewardship programmes are needed to prevent the emergence and spread of antibiotic resistance.

Keywords: Acinetobacter; India; multidrug resistance; antibiotic resistance; antibacterial susceptibility testing (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/15/1/153/pdf (application/pdf)
https://www.mdpi.com/1660-4601/15/1/153/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:15:y:2018:i:1:p:153-:d:127669

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().